About Dotamin 250mg / 5ml Dobutamine Injections
| Strength |
250 mg
|
| Pack Size |
5 ml
|
| Pack Type |
Vial
|
| Packaging Type |
5 ml in 1 vial
|
| Grade Standard |
Medicine Grade
|
| Usage/Application |
Clinical
|
| Brand Name |
Dotamin 250mg Injection
|
| Manufactured By |
Neon Laboratories Ltd
|
| Usages |
used for short-term treatment of cardiac decompensation
|
| Country of Origin |
Made in India
|
Dotamin 250mg Injection is a medicine used for short-term treatment of cardiac decompensation (low blood pressure due to poorly functioning heart) due to disease like heart failure, cardiogenic shock, or heart attack. It increases the blood pressure by increasing the pumping capacity of the heart.
How does Dotamin work?Dotamin functions as a cardiac stimulant by increasing myocardial contractility, thereby supporting heart function in critically ill patients. Its rapid onset of action allows it to deliver results within 1-2 minutes of intravenous administration. The medications effects are short-lived, requiring continuous infusion under close medical supervision for sustained benefit.
When is Dotamin typically used?Dotamin is reserved for hospital and clinical use in cases of acute heart failure, cardiac decompensation, and cardiogenic shock. Its use is limited to controlled medical environments where patient monitoring is possible due to its potent effects and specific contraindications.
What precautions should be taken during administration?Medical professionals should use Dotamin with caution in individuals with hypertension, arrhythmias, or recent myocardial infarction. It is contraindicated in patients with hypertrophic subaortic stenosis or known hypersensitivity to dobutamine. Continuous monitoring of vitals is essential during infusion.
FAQs of Dotamin 250mg / 5ml Dobutamine Injections:
Q: How is Dotamin 250mg/5ml administered to patients?
A: Dotamin is administered intravenously via infusion, typically within a hospital or clinical setting. Dosage is individualized based on the patients condition, usually starting at 2.510 mcg/kg/min, and must be supervised by experienced healthcare professionals.
Q: What conditions are treated with Dotamin injections?
A: Dotamin is primarily indicated for acute heart failure, cardiac decompensation, and cardiogenic shock. It provides inotropic support for both adults and children experiencing these critical cardiac conditions.
Q: When does Dotamin begin to take effect after administration?
A: The onset of action is rapid, generally occurring within 1 to 2 minutes after the intravenous infusion begins. Its effects diminish quickly once the infusion is stopped.
Q: Where should Dotamin be stored to maintain its efficacy?
A: Dotamin should be stored below 25C and protected from light. It must remain in its original ampoule packaging until used.
Q: What are the main practice guidelines for using Dotamin safely?
A: Only administer Dotamin in hospital or clinical settings with continuous monitoring. Avoid use in patients with hypertrophic subaortic stenosis or those with known hypersensitivity to dobutamine. Caution is advised in patients with hypertension, arrhythmias, or a history of myocardial infarction.
Q: What are the potential benefits of using Dotamin for critically ill patients?
A: Dotamins key benefit is the rapid improvement in cardiac contractility, which supports circulation and stabilizes patients in acute cardiac distress. Its fast action and short duration make it an essential intervention in emergencies under expert supervision.